Farmacognosia y Galenica-Tratado de Fitofármacos y Nutracéuticos-Alonso J
Tuesday, April 04, 2017 - EXTREM INSOLV EV...RAPORT DE EVALUARE ACTIVE FARMACIA GALENICA CS SRI,...
13
Transcript of Tuesday, April 04, 2017 - EXTREM INSOLV EV...RAPORT DE EVALUARE ACTIVE FARMACIA GALENICA CS SRI,...
![Page 1: Tuesday, April 04, 2017 - EXTREM INSOLV EV...RAPORT DE EVALUARE ACTIVE FARMACIA GALENICA CS SRI, Referitor la analiza activelor comparabile si cel de evaluat, facem urmatoarele precizari:](https://reader035.fdocuments.net/reader035/viewer/2022070212/6107d071e8f27c71a617ca53/html5/thumbnails/1.jpg)
![Page 2: Tuesday, April 04, 2017 - EXTREM INSOLV EV...RAPORT DE EVALUARE ACTIVE FARMACIA GALENICA CS SRI, Referitor la analiza activelor comparabile si cel de evaluat, facem urmatoarele precizari:](https://reader035.fdocuments.net/reader035/viewer/2022070212/6107d071e8f27c71a617ca53/html5/thumbnails/2.jpg)
![Page 3: Tuesday, April 04, 2017 - EXTREM INSOLV EV...RAPORT DE EVALUARE ACTIVE FARMACIA GALENICA CS SRI, Referitor la analiza activelor comparabile si cel de evaluat, facem urmatoarele precizari:](https://reader035.fdocuments.net/reader035/viewer/2022070212/6107d071e8f27c71a617ca53/html5/thumbnails/3.jpg)
![Page 4: Tuesday, April 04, 2017 - EXTREM INSOLV EV...RAPORT DE EVALUARE ACTIVE FARMACIA GALENICA CS SRI, Referitor la analiza activelor comparabile si cel de evaluat, facem urmatoarele precizari:](https://reader035.fdocuments.net/reader035/viewer/2022070212/6107d071e8f27c71a617ca53/html5/thumbnails/4.jpg)
![Page 5: Tuesday, April 04, 2017 - EXTREM INSOLV EV...RAPORT DE EVALUARE ACTIVE FARMACIA GALENICA CS SRI, Referitor la analiza activelor comparabile si cel de evaluat, facem urmatoarele precizari:](https://reader035.fdocuments.net/reader035/viewer/2022070212/6107d071e8f27c71a617ca53/html5/thumbnails/5.jpg)
![Page 6: Tuesday, April 04, 2017 - EXTREM INSOLV EV...RAPORT DE EVALUARE ACTIVE FARMACIA GALENICA CS SRI, Referitor la analiza activelor comparabile si cel de evaluat, facem urmatoarele precizari:](https://reader035.fdocuments.net/reader035/viewer/2022070212/6107d071e8f27c71a617ca53/html5/thumbnails/6.jpg)
![Page 7: Tuesday, April 04, 2017 - EXTREM INSOLV EV...RAPORT DE EVALUARE ACTIVE FARMACIA GALENICA CS SRI, Referitor la analiza activelor comparabile si cel de evaluat, facem urmatoarele precizari:](https://reader035.fdocuments.net/reader035/viewer/2022070212/6107d071e8f27c71a617ca53/html5/thumbnails/7.jpg)
![Page 8: Tuesday, April 04, 2017 - EXTREM INSOLV EV...RAPORT DE EVALUARE ACTIVE FARMACIA GALENICA CS SRI, Referitor la analiza activelor comparabile si cel de evaluat, facem urmatoarele precizari:](https://reader035.fdocuments.net/reader035/viewer/2022070212/6107d071e8f27c71a617ca53/html5/thumbnails/8.jpg)
![Page 9: Tuesday, April 04, 2017 - EXTREM INSOLV EV...RAPORT DE EVALUARE ACTIVE FARMACIA GALENICA CS SRI, Referitor la analiza activelor comparabile si cel de evaluat, facem urmatoarele precizari:](https://reader035.fdocuments.net/reader035/viewer/2022070212/6107d071e8f27c71a617ca53/html5/thumbnails/9.jpg)
![Page 10: Tuesday, April 04, 2017 - EXTREM INSOLV EV...RAPORT DE EVALUARE ACTIVE FARMACIA GALENICA CS SRI, Referitor la analiza activelor comparabile si cel de evaluat, facem urmatoarele precizari:](https://reader035.fdocuments.net/reader035/viewer/2022070212/6107d071e8f27c71a617ca53/html5/thumbnails/10.jpg)
![Page 11: Tuesday, April 04, 2017 - EXTREM INSOLV EV...RAPORT DE EVALUARE ACTIVE FARMACIA GALENICA CS SRI, Referitor la analiza activelor comparabile si cel de evaluat, facem urmatoarele precizari:](https://reader035.fdocuments.net/reader035/viewer/2022070212/6107d071e8f27c71a617ca53/html5/thumbnails/11.jpg)
![Page 12: Tuesday, April 04, 2017 - EXTREM INSOLV EV...RAPORT DE EVALUARE ACTIVE FARMACIA GALENICA CS SRI, Referitor la analiza activelor comparabile si cel de evaluat, facem urmatoarele precizari:](https://reader035.fdocuments.net/reader035/viewer/2022070212/6107d071e8f27c71a617ca53/html5/thumbnails/12.jpg)
![Page 13: Tuesday, April 04, 2017 - EXTREM INSOLV EV...RAPORT DE EVALUARE ACTIVE FARMACIA GALENICA CS SRI, Referitor la analiza activelor comparabile si cel de evaluat, facem urmatoarele precizari:](https://reader035.fdocuments.net/reader035/viewer/2022070212/6107d071e8f27c71a617ca53/html5/thumbnails/13.jpg)